CIBC Private Wealth Group
LTRN icon

CIBC Private Wealth Group’s Lantern Pharma LTRN Stock Holding History

CIBC Private Wealth Group’s Portfolio LTRN Stock Details LTRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$46.8K Buy
+15,432
New +$57.4K ﹤0.01% 1810

Other funds holding LTRN

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

CIBC Private Wealth Group's LTRN Position: Q4 2025 in Review

CIBC Private Wealth Group opened a new position in Lantern Pharma (LTRN) in Q4 2025: 15,432 shares worth $46.8K. The stake represents ﹤0.01% of the portfolio and ranks #1810 among its holdings.

33 funds tracked by Wall St. Rank hold LTRN as of Q4 2025.

  • CIBC Private Wealth Group held 15,432 shares of Lantern Pharma worth $46.8K as of Q4 2025.
  • Lantern Pharma was a new CIBC Private Wealth Group position in Q4 2025.
  • Lantern Pharma made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #1810 holding.
  • 33 funds tracked by Wall St. Rank held Lantern Pharma as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.